Psoriasis frequently progresses to PsA, and it has been uncertain whether drugs targeting TNF can delay or prevent it. This retrospective analysis examined progression rates in patients with severe ...
Findings reveal an increased risk of psoriatic arthritis (PsA) among female patients with severe skin psoriasis who have nail involvement and require oral systemic therapy for their condition. A ...
Tumor necrosis factor (TNF) inhibitor therapy was effective in reducing the likelihood that psoriasis would progress to psoriatic arthritis (PsA), a retrospective study indicated. Among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results